Literature DB >> 20100670

Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.

Veronica D Gonzalez1, Alan L Landay, Johan K Sandberg.   

Abstract

Innate immune responses are critical in the defense against viral infections. NK cells, myeloid and plasmacytoid dendritic cells, and invariant CD1d-restricted NKT cells mediate both effector and regulatory functions in this early immune response. In chronic uncontrolled viral infections such as HCV and HIV-1, these essential immune functions are compromised and can become a double edged sword contributing to the immunopathogenesis of viral disease. In particular, recent findings indicate that innate immune responses play a central role in the chronic immune activation which is a primary driver of HIV-1 disease progression. HCV/HIV-1 co-infection is affecting millions of people and is associated with faster viral disease progression. Here, we review the role of innate immunity and chronic immune activation in HCV and HIV-1 infection, and discuss how mechanisms of innate immunity may influence protection as well as immunopathogenesis in the HCV/HIV-1 co-infected human host. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20100670     DOI: 10.1016/j.clim.2009.12.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  28 in total

1.  A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Authors:  Diego A Vargas-Inchaustegui; Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co-infected patients.

Authors:  M K Jain; B Adams-Huet; D Terekhova; L E Kushner; R Bedimo; X Li; M Holodniy
Journal:  J Viral Hepat       Date:  2014-02-09       Impact factor: 3.728

3.  Hepatic immunopathology during occult hepacivirus re-infection.

Authors:  Cordelia Manickam; Amanda J Martinot; Rhianna A Jones; Valerie Varner; R Keith Reeves
Journal:  Virology       Date:  2017-09-13       Impact factor: 3.616

4.  Chronic immune activation is a distinguishing feature of liver and PBMC gene signatures from HCV/HIV coinfected patients and may contribute to hepatic fibrogenesis.

Authors:  Angela L Rasmussen; I-Ming Wang; Margaret C Shuhart; Sean C Proll; Yudong He; Razvan Cristescu; Chris Roberts; Victoria S Carter; Christopher M Williams; Deborah L Diamond; Janine T Bryan; Roger Ulrich; Marcus J Korth; Lisa V Thomassen; Michael G Katze
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

Review 5.  Delineating HIV-associated neurocognitive disorders using transgenic models: the neuropathogenic actions of Vpr.

Authors:  Christopher Power; Elizabeth Hui; Pornpun Vivithanaporn; Shaona Acharjee; Maria Polyak
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-15       Impact factor: 4.147

6.  NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infection.

Authors:  C Kuylenstierna; J E Snyder-Cappione; C P Loo; B R Long; V D Gonzalez; J Michaëlsson; M Moll; G Spotts; F M Hecht; D F Nixon; J K Sandberg
Journal:  Scand J Immunol       Date:  2011-02       Impact factor: 3.487

Review 7.  Dynamics of innate immunity are key to chronic immune activation in AIDS.

Authors:  Arndt Benecke; Michael Gale; Michael G Katze
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

Review 8.  The potential impact of coinfection on antimicrobial chemotherapy and drug resistance.

Authors:  Ruthie B Birger; Roger D Kouyos; C Jessica E Metcalf; Ted Cohen; Emily C Griffiths; Silvie Huijben; Michael J Mina; Victoriya Volkova; Bryan Grenfell
Journal:  Trends Microbiol       Date:  2015-05-29       Impact factor: 17.079

9.  Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients.

Authors:  David Eric Ouedraogo; Alain Makinson; Nils Kuster; Nicolas Nagot; Pierre-Alain Rubbo; Karine Bollore; Vincent Foulongne; Guillaume Cartron; Daniel Olive; Jacques Reynes; Jean-Pierre Vendrell; Edouard Tuaillon
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

10.  During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.

Authors:  Lenche Kostadinova; Carey L Shive; Chelsey Judge; Elizabeth Zebrowski; Anita Compan; Kelsey Rife; Amy Hirsch; Yngve Falck-Ytter; Daniela M Schlatzer; Xiaolin Li; Mark R Chance; Benigno Rodriguez; Daniel L Popkin; Donald D Anthony
Journal:  J Infect Dis       Date:  2016-08-17       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.